Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine Treatment.

Leoni RolfesSteffen PfeufferJana HackertMarc PawlitzkiTobias RuckWiebke SondermannMelanie KorsenHeinz WiendlSven G MeuthChristoph KleinschnitzRefik Pul

Published in: Neurology(R) neuroimmunology & neuroinflammation (2021)

This study provides Class IV evidence that skin-related AEs are frequent in patients with MS following cladribine in a real-world setting.

Keyphrases